Recursion Pharmaceuticals Inc (RXRX)
9.37
+0.11
(+1.19%)
USD |
NASDAQ |
Jun 17, 16:00
9.35
-0.02
(-0.21%)
After-Hours: 07:41
Recursion Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.021M |
| March 31, 2022 | 0.034M |
| December 31, 2021 | 0.034M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.034M |
| June 30, 2021 | 0.049M |
| March 31, 2021 | 0.071M |
| December 31, 2020 | 0.156M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
0.156M
Maximum
Dec 2020
0.0499M
Average
0.034M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
| Eli Lilly and Co | 7.886B |
| Viking Therapeutics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 7.219M |
| Marinus Pharmaceuticals Inc | 3.513M |